Table 4.
CON (n = 18) | LEN (n = 20) | p-Value | |
---|---|---|---|
∆ Total Cholesterol (mmol/L) | 0.36 (0.43) | −0.11 (0.50) | <0.01 |
∆ HDL Cholesterol (mmol/L) | 0.10 (0.14) | −0.07 (0.15) | <0.001 |
∆ LDL Cholesterol (mmol/L) | 0.30 (0.36) | −0.03 (0.43) | 0.02 |
∆ Triglycerides (mmol/L) | −0.21 (0.54) | −0.06 (0.73) | 0.51 |
∆ GLU (mmol/L) | −0.05 (0.44) | −0.06 (0.34) | 0.56 |
∆ INS (mmol/L) | −2.40 (8.84) | −3.83 (22.35) | 0.85 |
∆ HbA1c (%) | 0.06 (0.38) | 0.03 (0.17) | 0.56 |
∆ HOMA-IR | −0.59 (2.29) | −0.95 (5.23) | 0.87 |
Data represent mean change (∆) in fasting marker (post-intervention–pre-intervention) (standard deviation). p-values determined with ANOVA. Abbreviations: control, CON; lentil, LEN; high density lipoprotein, HDL; low density lipoprotein, LDL; glucose, GLU; insulin, INS; hemoglobin A1c, HbA1c; and homeostatic model of insulin resistance, HOMA-IR.